(Q43564955)

24 November 2017

Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease (English)

1 reference

24 November 2017

1 reference

1 reference

Rodríguez Díaz M

1

1 reference

24 November 2017

Abdala P

2

1 reference

24 November 2017

Barroso-Chinea P

3

1 reference

24 November 2017

Obeso J

4

1 reference

24 November 2017

González-Hernández T

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Behavioural Brain Research

24 November 2017

1 reference

24 November 2017

122

1 reference

24 November 2017

1

1 reference

24 November 2017

79-92

1 reference

Behavioral lateralization in rats: prenatal stress effects on sex differences.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Sex differences in behavioral despair: relationships between behavioral despair and open field activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Enhancement of audiogenic seizure by 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Undrugged rotational response in nigro-striatal system-lesioned rats is related to the previous early response to apomorphine when repeatedly administered.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Conditioning of the early behavioral response to apomorphine in the rotational model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Enhanced behavioral depressant effects of reserpine and -methyltyrosine after 6-hydroxydopamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Mapping of globus pallidus and ventral pallidum lesions that produce hyperkinetic treading

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Effects of 6-Hydroxydopamine on CNS Catecholamines, Spontaneous Motor Activity and Amphetamine Induced Hyperactivity in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Intracerebral SCH 23390 and catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: evidence for mediation by motor deficits rather than by reduced reward

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

L-Dopa repairs deficits in locomotor and investigatory exploration produced by denervation of catecholamine terminal fields in the forebrain of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Is the mesocortical dopaminergic system involved in Parkinson disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Distribution of Catecholamines in the Ventral Mesencephalon of Human Brain, with Special Reference to Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Central effects of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Rate of cell death in parkinsonism indicates active neuropathological process

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Catecholamines and neurologic diseases (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

A 6-hydroxydopamine-induced selective parkinsonian rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Iron-Mediated Generation of the Neurotoxin 6-Hydroxydopamine Quinone by Reaction of Fatty Acid Hydroperoxides with Dopamine: A Possible Contributory Mechanism for Neuronal Degeneration in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Discriminative and motor performance in rats after interference with dopamine neurotransmission with spiroperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Apomorphine lowers dopamine synthesis for up to 48 h: implications for drug sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

The catalepsy test: its ups and downs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Mechanisms of action of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Tremulous jaw movements in rats: a model of parkinsonian tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

A model for multisystem evaluation treatment of individuals with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Effect of 6-hydroxydopamine on some actions of tremorine and oxotremorine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Is interruption of the nigro-striatal dopamine system producing the "lateral hypothalamus syndrome"?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Adipsia and Aphagia after 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900168-1

7 January 2021

10.1016/S0166-4328(01)00168-1

Identifiers

DOI

1 reference

24 November 2017

1 reference